Intelligent Bio Solutions Inc. (INBS) Change in Accured Expenses (2022 - 2025)

Intelligent Bio Solutions' Change in Accured Expenses history runs 4 years deep, the most recent figure standing at $237202.0 for Q1 2025.

• In Q1 2025, Change in Accured Expenses rose 208.11% year-over-year to $237202.0; the TTM figure through Mar 2025 stood at -$774248.0 (down 261.22% YoY), while the FY2023 annual figure was -$25724.0, down 189.15% from the prior year.
• Change in Accured Expenses for Q1 2025 stood at $237202.0, up from -$1.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $237202.0 in Q1 2025, with the low at -$1.0 million in Q4 2024.
• The 4-year median for Change in Accured Expenses is $2261.0 (2023), against an average of -$70982.2.
• Peak annual rise in Change in Accured Expenses reached 7721.02% in 2024, while the deepest fall reached 44920.26% in 2024.
• Intelligent Bio Solutions' Change in Accured Expenses stood at $2905.0 in 2022, then fell by 22.17% to $2261.0 in 2023, then tumbled by 44920.26% to -$1.0 million in 2024, then soared by 123.41% to $237202.0 in 2025.
• Business Quant data shows INBS's Change in Accured Expenses at $237202.0 in Q1 2025, -$1.0 million in Q4 2024, and $221335.0 in Q3 2024.